Subscribe to our monthly newsletter.
Your email address will never be disclosed to any third party.
Read our privacy notice.



Post your news
Turkey BioExpo shows nearly fully booked
With only 8 weeks to go and over 75 exhibitors booked space, we now only have 15 booths left for BioExpo Shows and they are going quickly, so if this event is of interest to you why not book your space today or ask us to hold you a booth while you await the funding. Five exhibitions at the same time at the same venue. 17 – 19 April 2019 ICEC – Lütfi Kirdar International Congress and Exhibition Center, Istanbul, Turkey Cleanroom Analytech Biotecnica Pharmanext Nutrivision Cleanroom Technology Analysis & LAB Technology Biotechnology & Life Sciences Pharmaceutical Industry Nutraceutical Industry
21-02-2019  |  020x  |  News in brief
MIXOMAT mini laboratory blenders – Fits even in the smallest Fuchs Maschinen AG, Granges-Paccot
MIXOMAT mini laboratory blenders – Fits even in the smallest
Fuchs Maschinen AG, Granges-Paccot MIXOMAT drum blenders are used in the chemical and pharmaceutical industries for the blending and pre-blending of bulk materials. Among others, they are ideal for not optimally free-flowing powders and granules. The Mixomat drum blender program is modularly designed and includes blenders for all types of container sizes and applications. The smallest blender, the Mixomat mini (the latest development from Fuchs) is ideal for blending small quantity batches or carry out on-demand blending using containers of 0.5 to 2 litre capacities to process bulk materials of 2 kg/l maximum specific weight and 2 kg working load. This blender is fitted with the same characteristics of the large-sized drum blenders and can be directly used on site or in laboratory environment. The blender is fitted with the same functionalities as her bigger MIXOMAT-brothers: the blending drum is filled to a maximum of 70% of its capacity and rotated around its own axes during a preselected blending
21-02-2019  |  023x  |  Product description  | 
WuXi STA and BioLingus sign exclusive partnership
Shanghai and San diego, February 20, 2019: STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec – and BioLingus, a Swiss biotech company, announce they have formed an exclusive technology and marketing collaboration for sublingual delivery. Under the terms of the collaboration, WuXi STA will have exclusive access to BioLingus technology for sublingual and buccal delivery in the contract development and manufacturing organization (CDMO) sector. BioLingus has developed a novel platform – with patents secured in major countries around the world – to stabilize and deliver sublingually (orally under the tongue) drug targets including small molecules, peptides and proteins, that are currently administered to patients via injection. The collaboration will help further integrate the advantages of WuXi STA drug product services and expedite the development of BioLingus’ pipeline and usage of sublingual delivery technology. In 2017, WuXi STA merged with
20-02-2019  |  017x  |  News in brief
PEFTEC 2019 moves to Rotterdam
PEFTEC 2019 moves to Rotterdam
PEFTEC 2019, the 3rd International Conference and Exhibition on Petroleum, Refining and Environmental Technologies, will take place 22-23 May at the Rotterdam Ahoy centre in the Netherlands. Previous events were in Antwerp, but organiser Marcus Pattison says: “Rotterdam Ahoy is a vibrant, fresh facility, located in the middle of one of the world’s major petrochemical hubs. It also has superb transport links, so the move to Rotterdam will make a trip to PEFTEC even easier.” Rotterdam has Europe’s largest port and is situated at the heart of the ARRA cluster (Antwerp-Rotterdam-Rhine-Ruhr Area) with 5 oil refineries, 45 chemical companies, 5 biofuel producers, 2 biochemical factories and a number of major power stations. The port also represents a vitally important transit point for bulk materials between the European continent and overseas markets. PETEC 2019 is a focused event specialising in monitoring and analysis within Petroleum, Refining and Environmental applications.
20-02-2019  |  023x  |  News in brief  | 
Reliable Automated Cannabis Testing Solutions Hamilton Robotics Joins with Medicinal Genomics to provide HT-solutions
Reliable Automated Cannabis Testing Solutions
Hamilton Robotics Joins with Medicinal Genomics to provide HT-solutions Hamilton Robotics and Medicinal Genomics continue to combine their respective strengths to benefit the rapidly expanding and evolving cannabis testing market. As such, assay technologies based on Medicinal Genomics’ vast expertise in cannabis genetics are optimized for use on Hamilton’s automated liquid handling workstations. The collaborative solutions will be showcased at the 5th Annual Emerald Conference and detailed in the upcoming co-authored application note, titled, “Automated Cannabis DNA Purification and Microbial Safety Testing to Comply with Canadian and Individual U.S. State Requirements”. Featured in this latest application note are the SenSATIVAx® DNA Purification Kit to purify cannabis and microbial DNA from any matrix, and the qPCR-based PathoSEEK® Microbial Safety Testing Platform, which is the only microbial testing method validated on cannabis and designed for use with flowers, extracts and a variety of infused products. The highly validated assay
20-02-2019  |  014x  |  News in brief  | 
SkinBioTherapeutics on track
for development of scientifically based skin microbiome treatments UK based SkinBioTherapeutics is developing a range of scientifically validated treatments derived from probiotic bacteria for use in cosmetics, infection control products and for the treatment of eczema. Led by Professor Cath O’Neill from Manchester University, a world leader in this field, the company will have the results of a double-blinded, cream efficacy study in 120 volunteers in a few weeks which will be shared with interested commercial partners. This follows successful human studies in ensuring that the treatments do not irritate and that that they are effective moisturisers. The skin, the body’s largest organ, is colonised by a diverse range of microorganisms which has to be managed for long term good health. SkinBioTherapeutics, patented technology, has developed a range of products based on lysates - extracts of probiotic bacteria - which will help keep the skin healthier and treat certain conditions. The lysates work by increasing the skins barrier
19-02-2019  |  027x  |  News in brief
Following 6 items
LABinsights.net LABinsights.de LABinsights.nl
Newsletter archive
Service and contact
ContactDisclaimerPrivacyAdvertisingControl panel login